What is the appropriate treatment for a 60-year-old man with psoriasis limited to both arms and the face?

Treatment for Psoriasis on Arms and Face in a 60-Year-Old Male

Start with a combination of calcipotriene plus betamethasone dipropionate for the arms, and calcipotriene combined with low-potency topical corticosteroid (such as hydrocortisone) for the face. 1

Algorithmic Approach

For Arm Lesions (Non-Sensitive Site)

• First-line: Calcipotriene 0.005% + betamethasone dipropionate 0.064% combination product
  • Apply once daily for up to 52 weeks
  • This combination is more effective than either agent alone 1
  • In 52-week studies, 69-74% of patients achieved clear or almost clear status with no serious adverse events including striae or hypothalamic-pituitary-adrenal axis suppression 1

For Facial Lesions (Sensitive Site)

• First-line: Calcipotriene combined with hydrocortisone (low-potency corticosteroid)
  • Apply for 8 weeks initially
  • An 8-week RCT demonstrated that treatments containing hydrocortisone were significantly more effective on the face (odds ratio 2.01, P = 0.001) 1
  • Alternative if corticosteroid side effects are a concern: Topical calcineurin inhibitors (tacrolimus or pimecrolimus) are equally appropriate first-line options for facial psoriasis 2, 3

Why This Approach

The 2021 AAD-NPF guidelines provide Level A evidence (strongest recommendation) for vitamin D analogues combined with potent corticosteroids for body lesions, but facial skin requires special consideration 1. The face is a sensitive site prone to corticosteroid-induced atrophy, telangiectasia, and other adverse effects, particularly relevant in a 60-year-old patient who may have thinner skin 2, 4.

Key distinction: While potent corticosteroids work well on the arms, facial psoriasis specifically responds better to the combination of vitamin D analogues with LOW-potency corticosteroids rather than potent ones 1, 2.

Common Pitfalls to Avoid

• Do not use potent or ultrapotent corticosteroids on the face - this increases risk of atrophy, telangiectasia, and perioral dermatitis
• Do not use vitamin D analogues alone on the face initially - they can cause irritation in unstable psoriasis 2
• Avoid applying vitamin D analogues before phototherapy if you later add UV treatment - they should be applied after phototherapy to avoid inactivation by UVA and blocking of UVB 1
• In elderly patients (>60 years), monitor more closely for steroid-induced adverse events including purpura and secondary infections 4

If First-Line Fails

If topical therapy is inadequate after 8-12 weeks:

1. Consider phototherapy (UVB)
2. Escalate to systemic therapy (methotrexate, biologics) 2, 5
3. For elderly patients specifically, phototherapy, acitretin, methotrexate, and biologics are appropriate first-line systemic options 5

Duration and Monitoring

• Arms: Can safely continue combination therapy up to 52 weeks 1
• Face: Reassess at 8 weeks; may need to transition to maintenance with calcineurin inhibitors or intermittent low-potency corticosteroids to minimize long-term steroid exposure 2, 3